The Times of India  May 23  Comment 
Drug firm Novartis India today reported a sharp decline in standalone net profit at Rs 2.91 crore for the fourth quarter ended March 31, hit by reduction in product prices. The company had posted a net profit of Rs 22.83 crore for the...
GenEng News  May 19  Comment 
Novartis said it will eliminate 500 jobs at its headquarters in Basel, Switzerland, over the next 18 months—during which the pharma giant also plans to add 350 “high-tech” Swiss-based jobs. The jobs to be eliminated include...
FiercePharma  May 15  Comment 
​​​​​​​Rocked by a corruption scandal in Korea and facing a kickbacks probe in Greece, Novartis says it's strengthening and simplifying its global ethics and compliance approach.
FiercePharma  May 15  Comment 
Next March, GlaxoSmithKline will have the option to buy out Novartis’ stake in the pair’s industry-leading consumer health venture. And it's said to be preparing an offer already.
FierceBiotech  May 12  Comment 
Eli Lilly has posted positive data from three phase 3 trials of galcanezumab in migraine patients. But while the data show galcanezumab cuts the number of days patients suffer from migraines, they fell short of delivering a knockout blow to Amgen...
FiercePharma  May 10  Comment 
Novartis has already undercut Pfizer’s Ibrance on price with its newcomer breast cancer drug Kisqali. Now it’s looking for the convenience edge, too.


Fuerralz? That's marvelously good to know.

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki